[Contribution to the study of the secondary haemorrhagic syndrome following administration of anti-coagulant drugs. The efficacy of the ellagic acid].
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001780:Blood Coagulation Tests; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D051381:Rats; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin
Contributo allo studio della sindrome emorragica secondaria dopo la somministrazione di anticoagulanti. L'efficacia dell'acido ellagico.